| 1 |
32968106 | Modulation of CYP2C9 activity and hydrogen peroxide production by cytochrome b5. | 2020 Sep 23 |
1 |
| 2 |
29885857 | From epidemiology to treatment: Aspirin's prevention of brain and breast-cancer and cardioprotection may associate with its metabolite gentisic acid. | 2018 Aug 1 |
2 |
| 3 |
26517138 | The Implication of the Polymorphisms of COX-1, UGT1A6, and CYP2C9 among Cardiovascular Disease (CVD) Patients Treated with Aspirin. | 2015 |
3 |
| 4 |
21966608 | Polymorphisms of Aspirin-Metabolizing Enzymes CYP2C9, NAT2 and UGT1A6 in Aspirin-Intolerant Urticaria. | 2011 Oct |
6 |
| 5 |
20445534 | CYP2C9*3 Loss-of-Function Allele Is Associated With Acute Upper Gastrointestinal Bleeding Related to the Use of NSAIDs Other Than Aspirin. | 2010 Jun |
4 |
| 6 |
20586862 | Aspirin-induced peptic ulcer and genetic polymorphisms. | 2010 May |
1 |
| 7 |
19067731 | The genetics of antiplatelet drug resistance. | 2009 Jan |
1 |
| 8 |
19255811 | Should we test for CYP2C9 before initiating anticoagulant therapy in patients with atrial fibrillation? | 2009 May |
2 |
| 9 |
20214591 | Pharmacogenomics in aspirin intolerance. | 2009 Nov |
3 |
| 10 |
17085674 | Genetic variants of UGT1A6 influence risk of colorectal adenoma recurrence. | 2006 Nov 1 |
1 |
| 11 |
16305586 | Polymorphisms in genes encoding acetylsalicylic acid metabolizing enzymes are unrelated to upper gastrointestinal health in cardiovascular patients on acetylsalicylic acid. | 2005 Dec |
4 |
| 12 |
15290664 | A prospective study of genetic polymorphisms in the cytochrome P-450 2C9 enzyme and the risk for distal colorectal adenoma. | 2004 Aug |
2 |
| 13 |
14586772 | Characterization of six base pair deletion in the putative HNF1-binding site of human PXR promoter. | 2003 |
1 |
| 14 |
11325819 | CYP2C9 and UGT1A6 genotypes modulate the protective effect of aspirin on colon adenoma risk. | 2001 May 1 |
3 |